Literature DB >> 31191840

Gene screening of colorectal cancers via network analysis.

Vahid Mansouri1, Mostafa Rezaei Tavirani1, Sina Rezaei Tavirani2.   

Abstract

AIM: Identifying crucial genes related to colorectal cancers via protein-protein interaction (PPI) network analysis is the aim of this study.
BACKGROUND: colorectal cancer as major reason of mortality is evaluated by genetic and proteomic approaches to find suitable biomarkers. Chromosomal instability plays crucial role in CRC. Expression change of large numbers of genes is reported.
METHODS: Differentially expressed genes related to CRCs which obtained from different proteomic methods were extracted from a review article of Paula Álvarez-Chaver et al. The genes interacted by Cytoscape software via STRING database. The central nodes determined and were enriched for biological terms by ClueGO. Action map for central genes was illustrated by CluePedia. The critical genes in CRC were introduced.
RESULTS: Among 123 query genes, 114 one recognized by software and were included in the network. SRC, EGFR, PCNA, IL8, CTNNB1, TIMP1, CDH1, and HSPD1 were determined as central genes. After gene ontology analysis SRC, EGFR, and CDH1 were identified as critical genes related to CRC.
CONCLUSION: It seems that SRC, EGFR, and CDH1 and the related pathways are possible biomarkers for CRC.

Entities:  

Keywords:  Biomarker; Colorectal cancer; Gene

Year:  2019        PMID: 31191840      PMCID: PMC6536014     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol Bed Bench        ISSN: 2008-2258


Introduction

Colorectal cancer (CRC) is known as a major reason of morbidity and mortality by cancers (1). There are evidence that early detection and treatment of CRCs are correlated to decrement of mortality rate (2). Serious efforts by researchers are opened new fields in personalized cancer medicine about CRCs to find precise diagnostic and therapeutic methods based on genetic milieu (3). It is reported that clinical behavior of CRCs is caused by different molecular level especially chromosomal instability (4). Deregulation of many genes such as EGFR and cyclooxygenase 2 in CRC patients is confirmed (5, 6). It is reported that carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) levels are elevated in CRCs (7). Since expression change of large numbers of genes is associated with diseases, introducing limited numbers of them as diagnostic or therapeutic biomarkers is aim of numerous researchers. Using screening methods and validation tests can provide useful tools to find effective biomarkers (8, 9). PPI network analysis is an efficient method to screen large numbers of genes based on interaction between them. In this approach the query genes are interacted in and interactome (10) in two style; scale free network and non-scale free network. Usually gene networks are scale free and the elements of network can be differentiated based on centrality parameters such as degree, betweenness centrality, closeness centrality, and stress (11, 12). The nodes of network which have high numbers of connections are known as hubs and play crucial role in network integrity. Bottleneck nodes are characterized by high value betweenness. Common hubs and bottlenecks which are called hub-bottlenecks are critical elements of PPI network (13). Based on network analysis, it is possible to find common pathway between two diseases. In this regard, investigation indicates that there are common molecular features between colon and breast cancers (14). Many differentially expressed genes in CRC patients are introduced, screen of them to find crucial ones is aim of this study.

Methods

Paula Álvarez-Chaver et al. (2014) published a review about CRC biomarkers that were discovered by different tolls of proteomics from various biological samples (15). In the present study the 123 introduced biomarkers in this report are used to screen via PPI network analysis (see table S1). The genes included in interacted unit by Cytoscape software version 3.6.0 (16) and STRING database (17). The constructed network was analyzed by Network analyzer and the hub-bottlenecks were determined based on degree values and betweenness centrality. Common hub-bottlenecks and top nodes based on closeness centrality and stress were identified as central nodes. Action map including activation, inhibition, and expression were illustrated for the central nodes by CluePedia (18). Kapa score is considered as default value in CluePedia. Biological terms related to the central genes were determined by ClueGO (19) and were clustered. P value less than 0.05 was considered. Function and role of central nodes in CRC were discussed and interpreted in details.

Results

PPI network including 114 DEGs was constructed (see figure 1). The network contains 9 isolated nodes and a main connected component (105 nodes and 409 edges). Top 10% of nodes based on degree value including SRC, EGFR, CTNNB1, CDH1, IL8, PCNA, TIMP1, HSPD1, PTPRC, and SERPINA1 were selected as hubs. Top 10 nodes regarding betweenness centrality contain SRC, EGFR, PCNA, IL8, CTNNB1, TIMP1, HSPB1, CDH1, SPTAN1, and HSPD1 were determined as bottlenecks. Common hubs and bottlenecks including SRC, EGFR, PCNA, IL8, CTNNB1, TIMP1, CDH1, and HSPD1 were identified as hub-bottlenecks. All hub-bottlenecks were included in top nodes based on closeness centrality and stress (see table 1). Action map including expression, activation, and inhibition relative to the hub-bottlenecks is illustrated in the figure 2.
Figure 1

PPI network of colon cancer including 9 isolated nodes and a main connected component

Table 1

Hub-bottlenecks of colorectal cancer network based on data from proteomic reports. These nodes are included in top nodes based on closeness centrality and stress

RnamedescriptionDBCCCStress
1SRCv-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)360.200.589508
2EGFRepidermal growth factor receptor350.160.577840
3CTNNB1catenin (cadherin-associated protein), beta 1, 88kDa230.070.493608
4CDH1cadherin 1, type 1, E-cadherin (epithelial)220.060.492880
5IL8interleukin 8220.090.515086
6PCNAproliferating cell nuclear antigen220.090.514782
7TIMP1TIMP metallopeptidase inhibitor 1190.060.493924
8HSPD1heat shock 60kDa protein 1 (chaperonin)180.050.462548
Figure 2

Action map including activation, inhibition, and expression relative to the 8 hub-bottlenecks. Blue, green, and red colors refer to expression, activation, and inhibition actions. Kapa score is considered as default value in CluePedia

Hub-bottlenecks of colorectal cancer network based on data from proteomic reports. These nodes are included in top nodes based on closeness centrality and stress PPI network of colon cancer including 9 isolated nodes and a main connected component Action map including activation, inhibition, and expression relative to the 8 hub-bottlenecks. Blue, green, and red colors refer to expression, activation, and inhibition actions. Kapa score is considered as default value in CluePedia Biological terms relative to the 8 hub-bottlenecks. The colored terms are names of groups. Grouping p value and p value ≤ 0.05 were considered Further investigation about biological terms related to the hub-bottlenecks is shown in the figure 3. Numbers of 60 terms are identified which are attributed to the 8 central nodes. The determined terms are clustered in 6 classes including SRC auto phosphorylation is positively regulated by InlA-bound CDH1, Phosphorylation of EGFR by SRC kinase, proMMP9 binds TIMP1, interleukin-8 receptor binding, purine-specific mismatch base pair DNA N-glycosylase activity, and regulation of T cell mediated immune response to tumor cell. Graphical presentation of 6 groups is shown in the figure 4.
Figure 3

Biological terms relative to the 8 hub-bottlenecks. The colored terms are names of groups. Grouping p value and p value ≤ 0.05 were considered

Figure 4

Six clusters of biological term relative to the 8 central nodes are shown. Names of groups correspond to the group colors are written in the foot of figure.

Discussion

Introducing 123 cancer markers is an opportunity to find the best ones. It is possible to screen and select the crucial individuals that are prominent roles in onset and progress of CRC. Numbers of 114 genes among 123 ones (about 93%) were recognized by STRING database. The network was included 9 isolated nodes (about 8%) and a main connected component contains 105 nodes and 409 edges. Numbers of 8 central nodes were introduced. In many studies hubs or bottlenecks are introduced as central node, however it is reported that hub-bottlenecks are crucial genes or proteins. In this investigation the hub-bottlenecks which were top nodes based on both closeness centrality and stress were introduced as central nodes. This procedure indicates that the selected central nodes are potent central nodes and with high rate of confidence are the critical nodes of the studied network. Action map analysis revealed that except PCNA and HSPD1 the other central nodes are participated in the action map. As it is shown in the table 1, these two genes are in the row positions 6 and 8, therefore the weaker hubs are among the identified central nodes. Also, it is clear that row 7 is occupied by TIMP1. This gene is an individual among interacted genes in action map which only is regulated by CXCL8 (IL8) and has no regulatory effect on the other genes. Ignoring Timp1, the 5 remained genes including SRC, EGFR, IL8, CTNNB1, and CDH1 are highly connected to each other. As it is depicted in the figures 3 and 4, numbers of 60 biological terms related to the 8 central nodes are identified which are groups in the 6 clusters. Two clusters including “SRC autophosphorylation is positively regulated by InlA-bound CDH1” and “Phosphorylation of EGFR by SRC kinase” contain 51 terms or 85% all biological terms. It seems that these two classes of biological terms are the core of terms related to the central nodes. As it is appeared both groups are concerned by SRC, CDH1, and EGFR genes. As it is shown in the action map IL8 (CXCL8) has no inhibition link with the other elements of network and it is activated by CTNNB1 and EGFR. IL8 also has no activator activity on the other nodes of the network. CTNNB1 is the third elements in the table 1. Comparison between CTNNB1 and the top 2 central nodes shows considerable differences between them based on degree vale and the other centrality parameters. Finally based on these findings, SCR, EGFR, and CDH1 can be considering as critical genes which are involved in CRC. In following part, functional roles of these three critical genes in body and cancers are discussed: SRC is an important element in signal transduction pathways in normal and cancerous cells. Different pathways are identified that are related to SRC such as cell survival, adhesion, division and motility (20). Six clusters of biological term relative to the 8 central nodes are shown. Names of groups correspond to the group colors are written in the foot of figure. □ SRC auto phosphorylation is positively regulated by InlA-bound CDH. □ Phosphorylation of EGFR by SRC kinase. □ proMMP9 binds TIMP1. □ interleukin-8 receptor binding. □ purine-specific mismatch base pair DNA N-glycosylase activity. □ Regulation of T cell mediated immune response to tumor cell. Investigations indicate that SRC is up-regulated in various cancers such as brain, colon, pancreas, and breast cancers. High level of SRC protein is found in cancerous tissue relative to adjacent normal tissue. It is reported that there is correlation between SRC level and malignancy process progression (21). Bosutinib, dasatinib, saracatinib, and KX01 are introduced as SRC inhibitors (22). EGFR the other crucial genes codes the transmembrane tyrosine kinase which activated by EGF family ligand. EGFR activation leads to activation of MAPK signaling pathway that is responsible for cell proliferation promotion (23). Deregulation of EGFR in wide varieties of tumors is reported. Since inhibition of EGFR in chemotherapy is an important aim, two classes of EGFR inhibitors are identified including monoclonal antibodies such as cetuximab (Erbitux) which target extracellular domain of EGFR and the other class of small molecule tyrosine kinase inhibitors as like erlotinib and gefitinib (24). CDH1 the third crucial protein in this analysis is a critical agent in cell-cell adhesion. CDH1 is known as tumor suppressor and its down regulation in several cancers such as gastric cancer is reported (25). There is evidence that CDH1 gene hyper methylation is associated with CRC (26). As it is reported CDH1 and CDH13 methylation in serum can be considered as cervical cancer markers (27). It seems that SRC, EGFR, and CDH1 are suitable biomarker candidates for CRC. However, quantity profiling of the elements of this panel may be useful tool in diagnosis and follow of CRC patients. Besides diagnostic features, these genes may be a appreciate drug targets in CRC disease.
  26 in total

1.  Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors.

Authors:  Fatima A Haggar; Robin P Boushey
Journal:  Clin Colon Rectal Surg       Date:  2009-11

Review 2.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

Authors:  Nader Rifai; Michael A Gillette; Steven A Carr
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

Review 3.  Role of Src expression and activation in human cancer.

Authors:  R B Irby; T J Yeatman
Journal:  Oncogene       Date:  2000-11-20       Impact factor: 9.867

4.  Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer.

Authors:  J M Wheeler; H C Kim; J A Efstathiou; M Ilyas; N J Mortensen; W F Bodmer
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

Review 5.  Molecular origins of cancer: Molecular basis of colorectal cancer.

Authors:  Sanford D Markowitz; Monica M Bertagnolli
Journal:  N Engl J Med       Date:  2009-12-17       Impact factor: 91.245

6.  Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.

Authors:  Shirin Khambata-Ford; Christopher R Garrett; Neal J Meropol; Mark Basik; Christopher T Harbison; Shujian Wu; Tai W Wong; Xin Huang; Chris H Takimoto; Andrew K Godwin; Benjamin R Tan; Smitha S Krishnamurthi; Howard A Burris; Elizabeth A Poplin; Manuel Hidalgo; Jose Baselga; Edwin A Clark; David J Mauro
Journal:  J Clin Oncol       Date:  2007-08-01       Impact factor: 44.544

7.  CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients.

Authors:  Andreas Widschwendter; Lennart Ivarsson; Anya Blassnig; Hannes M Müller; Heidi Fiegl; Annemarie Wiedemair; Elisabeth Müller-Holzner; Georg Goebel; Christian Marth; Martin Widschwendter
Journal:  Int J Cancer       Date:  2004-03-20       Impact factor: 7.396

Review 8.  Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer.

Authors:  Alberto Bardelli; Salvatore Siena
Journal:  J Clin Oncol       Date:  2010-01-25       Impact factor: 44.544

9.  Metagenomic biomarker discovery and explanation.

Authors:  Nicola Segata; Jacques Izard; Levi Waldron; Dirk Gevers; Larisa Miropolsky; Wendy S Garrett; Curtis Huttenhower
Journal:  Genome Biol       Date:  2011-06-24       Impact factor: 13.583

10.  ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks.

Authors:  Gabriela Bindea; Bernhard Mlecnik; Hubert Hackl; Pornpimol Charoentong; Marie Tosolini; Amos Kirilovsky; Wolf-Herman Fridman; Franck Pagès; Zlatko Trajanoski; Jérôme Galon
Journal:  Bioinformatics       Date:  2009-02-23       Impact factor: 6.937

View more
  3 in total

1.  Assessment of colon cancer molecular mechanism: a system biology approach.

Authors:  Babak Arjmand; Mahmood Khodadoost; Somayeh Jahani Sherafat; Mostafa Rezaei Tavirani; Nayebali Ahmadi; Maryam Hamzeloo Moghadam; Sina Rezaei Tavirani; Binazir Khanabadi; Majid Iranshahi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

2.  14,15-Epoxyeicosatrienoic Acid Protect Against Glucose Deprivation and Reperfusion-Induced Cerebral Microvascular Endothelial Cells Injury by Modulating Mitochondrial Autophagy via SIRT1/FOXO3a Signaling Pathway and TSPO Protein.

Authors:  Youyang Qu; Jinlu Cao; Di Wang; Shu Wang; Yujie Li; Yulan Zhu
Journal:  Front Cell Neurosci       Date:  2022-04-26       Impact factor: 6.147

3.  The effect of intestinal microbiota metabolites on HT29 cell line using MTT method in patients with colorectal cancer.

Authors:  Somayeh Jahani-Sherafat; Masoumeh Azimirad; Hajieh Ghasemian-Safaei; Hadi Ahmadi Amoli; Sharareh Moghim; Ghazal Sherkat; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2019
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.